Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.06 USD | -1.76% | -3.34% | -10.18% |
Jun. 05 | Catalyst Pharmaceuticals Insider Sold Shares Worth $276,735, According to a Recent SEC Filing | MT |
May. 30 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.18% | 1.81B | |
+0.85% | 92.4B | |
-3.03% | 38.08B | |
-10.65% | 34.05B | |
+74.71% | 27.77B | |
-13.06% | 16B | |
-1.85% | 14.1B | |
-11.15% | 11.91B | |
+169.04% | 10.37B | |
-50.19% | 10.2B |
- Stock Market
- Equities
- CPRX Stock
- News Catalyst Pharmaceuticals, Inc.
- Catalyst Pharmaceuticals CEO Patrick McEnany to Retire at End of 2023